News
A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...
Early symptoms like fatigue, breathlessness, swelling mimic common heart issues, causing cardiac amyloidosis to go undetected ...
Zacks Investment Research on MSN21h
Amgen's Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly
Amgen AMGN reported second-quarter 2025 adjusted earnings of $6.02 per share, which beat the Zacks Consensus Estimate of ...
CRD-750 is the first clinical-stage PDE9 inhibitor to be evaluated in patients in both types of chronic heart failure The CYCLE-1-REF trial is evaluating patients with heart failure with reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback